Puig-Domingo, M., Luque, R. M., Reverter, J. L., López-Sánchez, L. M., Gahete, M. D., Culler, M. D., . . . Castaño, J. P. (2014). The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Puig-Domingo, Manel, et al. The Truncated Isoform of Somatostatin Receptor5 (sst5TMD4) Is Associated with Poorly Differentiated Thyroid Cancer. Public Library of Science (PLoS), 2014.
Cita MLA (8a ed.)Puig-Domingo, Manel, et al. The Truncated Isoform of Somatostatin Receptor5 (sst5TMD4) Is Associated with Poorly Differentiated Thyroid Cancer. Public Library of Science (PLoS), 2014.
Precaución: Estas citas no son 100% exactas.